View drug registration information details.
| Items | Registration information |
|---|
| ID | 402 |
|---|
| No | 402 |
|---|
| Brand Name | ABEVMY 100 |
|---|
| Ingredients | BEVACIZUMAB (R-DNA ) 100 MG/4 ML |
|---|
| Dosage Form | SOLUTION FOR INFUSION |
|---|
| Primary Packaging | VIAL |
|---|
| Storage | |
|---|
| Shelf Life | 2 YEARS |
|---|
| Pack Size | BOX OF 1 VIAL X 4 ML |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | TREATMENT OF ADULT PATIENTS WITH METASTATIC CARCINOMA OF TH E COLON OR RECTUM (IN COMBINATION WITH FLUOROPYRIMIDINE BASED CHEMOTHERAPY) |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | CLEAR TO SLIGHTLY OPALESCENT, COLORLESS TO PALE BROWN LIQUID |
|---|
| Note | |
|---|
| License Owner | DKSH LAOS COMPANY LIMITED |
|---|
| Manufacturer | BIOCON LIMITED |
|---|
| Country | INDIA |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 08 I 5268/22 |
|---|
| FDD Registration Date | 26-AUG-2022 |
|---|
| Expiry Date | 25-AUG-2025 |
|---|
Back to drug list
|
